- Home
- KXIN vs VYNE Comparison
KXIN vs VYNE Comparison
Compare KXIN & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- VYNE
- Stock Information
- Founded
- KXIN 2015
- VYNE 2003
- Country
- KXIN China
- VYNE United States
- Employees
- KXIN N/A
- VYNE N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- KXIN Consumer Discretionary
- VYNE Health Care
- Exchange
- KXIN Nasdaq
- VYNE Nasdaq
- Market Cap
- KXIN 7.0M
- VYNE 7.9M
- IPO Year
- KXIN N/A
- VYNE 2018
- Fundamental
- Price
- KXIN $0.74
- VYNE $0.31
- Analyst Decision
- KXIN
- VYNE Buy
- Analyst Count
- KXIN 0
- VYNE 2
- Target Price
- KXIN N/A
- VYNE $8.00
- AVG Volume (30 Days)
- KXIN 394.5K
- VYNE 1.8M
- Earning Date
- KXIN 11-26-2019
- VYNE 11-06-2025
- Dividend Yield
- KXIN N/A
- VYNE N/A
- EPS Growth
- KXIN N/A
- VYNE N/A
- EPS
- KXIN N/A
- VYNE N/A
- Revenue
- KXIN $95,000.00
- VYNE $476,000.00
- Revenue This Year
- KXIN N/A
- VYNE N/A
- Revenue Next Year
- KXIN N/A
- VYNE N/A
- P/E Ratio
- KXIN N/A
- VYNE N/A
- Revenue Growth
- KXIN N/A
- VYNE N/A
- 52 Week Low
- KXIN $0.57
- VYNE $0.28
- 52 Week High
- KXIN $29.54
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- KXIN 48.58
- VYNE 32.83
- Support Level
- KXIN $0.70
- VYNE $0.28
- Resistance Level
- KXIN $1.09
- VYNE $0.33
- Average True Range (ATR)
- KXIN 0.12
- VYNE 0.02
- MACD
- KXIN 0.02
- VYNE 0.03
- Stochastic Oscillator
- KXIN 33.42
- VYNE 50.00
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.